Abstract: A process for creating acellular donor soft tissue by removing contaminants such as cells by extraction using a fluid at supercritical temperature and pressures while preserving the integrity of the soft tissue. The soft tissue is maintained in contact with the fluid in a pressure vessel at supercritical temperature and pressures for a period of time and then the pressure vessel is rapidly depressurized.
Type:
Grant
Filed:
October 6, 2011
Date of Patent:
March 10, 2015
Assignee:
Novasterilis, Inc.
Inventors:
David C. Burns, Anthony R. Eisenhut, Renee Christopher
Abstract: A method for sterilizing a ground meat product through the application supercritical CO2 during the processing of the meat by introducing supercritical CO2 into an extruder as the meat passes through the extruder while controlling the pressure and speed at which the meat passes through the extruder to maintain the meat in contact with the supercritical CO2 for a time sufficient achieve a log reduction in colony forming units of microbial contaminants.
Type:
Application
Filed:
January 10, 2013
Publication date:
July 10, 2014
Applicant:
Novasterilis, Inc.
Inventors:
David Burns, Thomas Steffie, Alecia Eppelsheimer
Abstract: Treating absorbable sutures that have been sterilized using ethylene oxide with carbon dioxide at or near its supercritical pressure and temperature conditions to remove any residual ethylene oxide.
Abstract: Whole organisms are inactivated by at least a factor of 106 using carbon dioxide at or near its supercritical pressure and temperature conditions.
Abstract: A process for cleaning donor soft tissue by removing contaminants by extraction using a fluid at supercritical temperature and pressures while preserving the integrity of the tissue.
Type:
Grant
Filed:
January 24, 2008
Date of Patent:
October 11, 2011
Assignee:
Novasterilis
Inventors:
David C. Burns, Anthony R. Eisenhut, Renee Christopher, Tim W. Christensen
Abstract: A sterilization method for drugs to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores is effective by subjecting the drugs to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions and controlling the pressurization and depressurization rates.
Type:
Grant
Filed:
August 10, 2007
Date of Patent:
September 6, 2011
Assignee:
Novasterilis
Inventors:
David C. Burns, Rebecca J. Humphrey, Anthony R. Eisenhut, Tim W. Christensen
Abstract: The invention relates to a method for forming a molded article during sterilization and under high pressure utilizing a supercritical fluid as a sterilization fluid, whereby the pressurization and depressurization rates are controlled to form molded articles.
Type:
Grant
Filed:
November 25, 2008
Date of Patent:
August 2, 2011
Assignee:
Novasterilis
Inventors:
Anthony R. Eisenhut, J. Anastasia Kazenski, Renee A. Christopher
Abstract: Whole organisms are inactivated by at least a factor of 106 using carbon dioxide at or near its supercritical pressure and temperature conditions.
Abstract: A method is disclosed that produces allografts from matrices typically containing demineralized bone matrix (DBM) powder, demineralized bone matrix gel, demineralized bone matrix paste, bone cement, cancellous bone, or cortical bone and mixtures thereof. The matrices are sterilized utilizing supercritical CO2 in the presence of a sterilizing additive and an entrainer such as an alkaline earth metal compound, preferably CaCO3. The resultant allograft materials have a reduced rate of rejection when used in allograft procedures including, bone, cartilage, tendon, and ligament grafting procedures.
Type:
Grant
Filed:
April 11, 2008
Date of Patent:
August 10, 2010
Assignee:
Novasterilis, Inc.
Inventors:
Renee A. Christopher, J. Anastasia Nichols
Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
Type:
Grant
Filed:
June 17, 2004
Date of Patent:
September 19, 2006
Assignee:
NovaSterilis Inc.
Inventors:
Timothy Wayne Christensen, David Carroll Burns, Angela Lydia White, Bruce Ganem, Anthony Romey Eisenhut
Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
Type:
Application
Filed:
June 17, 2004
Publication date:
February 3, 2005
Applicant:
NovaSterilis Inc.
Inventors:
Timothy Christensen, David Burns, Angela White, Bruce Ganem, Anthony Eisenhut